Dr. David Jacob Liss, M.D. Internal Medicine - Critical Care Medicine Medicare: Medicare Enrolled Practice Location: 19250 Sw 65th Ave, Suite 135, Tualatin, OR 97062 Phone: 503-692-8560 Fax: 503-692-8562 |
News Archive
Researchers from The University of Queensland's Institute for Molecular Bioscience (IMB), and the Centre for Microscopy and Microanalysis used electron microscopy to uncover new structures, 100,000th of a mm in size, which are involved in the very first step of particle and nutrient uptake into cells.
Brought to you by Break Dengue, Dengue Track is a novel approach to disease mapping which could also be used to tracking Zika virus or Malaria.
Medtronic, Inc. today announced the first implant in a clinical trial in Japan that will evaluate the safety and effectiveness of the Medtronic CoreValve System.
"We need to change how we look at obesity, stop obsessing on weight and BMI and, above all, redefine the proper clinical use of weight loss drugs," says noted obesity expert Dr. Jean-Pierre Després, delivering the Heart and Stroke Foundation of Canada Lecture at the Canadian Cardiovascular Congress 2007.
AstraZeneca today announced that the Phase 3 SUMIT study of selumetinib in combination with dacarbazine for the treatment of patients with metastatic uveal melanoma did not meet its primary endpoint of progression free survival. This combination therapy showed an adverse event profile generally consistent with current knowledge of the safety profiles of dacarbazine and selumetinib.
› Verified 6 days ago